Nuclear Abnormalities in LMNA p.(Glu2Lys) Variant Segregating with LMNA-Associated Cardiocutaneous Progeria Syndrome

被引:0
|
作者
Wilke, Matheus V. M. B. [1 ]
Wick, Myra [2 ,3 ]
Schwab, Tanya L. [4 ]
Starosta, Rodrigo Tzovenos [5 ,6 ]
Clark, Karl J. [7 ]
Connolly, Heidi M. [8 ]
Klee, Eric W. [1 ,3 ,9 ]
机构
[1] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Mol Hematol, Rochester, MN 55905 USA
[5] Washington Univ, Div Med Genet & Genom, St Louis, MO 63130 USA
[6] Univ Fed Rio Grande do Sul, Grad Program Gastroenterol & Hepatol, BR-90610000 Porto Alegre, Brazil
[7] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[8] Mayo Clin, Dept Cardiol, Rochester, MN 55905 USA
[9] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN 55905 USA
关键词
atypical progeroid syndrome; LMNA; mitral valve calcification; nuclear abnormalities; case report; VASCULAR CALCIFICATION; MOUSE MODEL;
D O I
10.3390/genes15010112
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The LMNA gene encodes lamin A and lamin C, which play important roles in nuclear organization. Pathogenic variants in LMNA cause laminopathies, a group of disorders with diverse phenotypes. There are two main groups of disease-causing variants: missense variants affecting dimerization and intermolecular interactions, and heterozygous substitutions activating cryptic splice sites. These variants lead to different disorders, such as dilated cardiomyopathy and Hutchinson-Gilford progeria (HGP). Among these, the phenotypic terms for LMNA-associated cardiocutaneous progeria syndrome (LCPS), which does not alter lamin A processing and has an older age of onset, have been described. Here, we present the workup of an LMNA variant of uncertain significance, NM_170707.2 c. 4G>A, p.(Glu2Lys), in a 36-year-old female with severe calcific aortic stenosis, a calcified mitral valve, premature aging, and a family history of similar symptoms. Due to the uncertainty of in silico predictions for this variant, an assessment of nuclear morphology was performed using the immunocytochemistry of stable cell lines to indicate whether the p.(Glu2Lys) had a similar pathogenic mechanism as a previously described pathogenic variant associated with LCPS, p.Asp300Gly. Indirect immunofluorescence analysis of nuclei from stable cell lines showed abnormal morphology, including lobulation and occasional ringed nuclei. Relative to the controls, p.Glu2Lys and p.Asp300Gly nuclei had significantly (p < 0.001) smaller average nuclear areas than controls (mean = 0.10 units, SD = 0.06 for p.Glu2Lys; and mean = 0.09 units, SD = 0.05 for p.Asp300Gly versus mean = 0.12, SD = 0.05 for WT). After functional studies and segregation studies, this variant was upgraded to likely pathogenic. In summary, our findings suggest that p.Glu2Lys impacts nuclear morphology in a manner comparable to what was observed in p.Asp300Gly cells, indicating that the variant is the likely cause of the LCPS segregating within this family.
引用
收藏
页数:10
相关论文
共 23 条
  • [1] LMNA-associated cardiocutaneous progeria: An inherited autosomal dominant premature aging syndrome with late onset
    Kane, Megan S.
    Lindsay, Mark E.
    Judge, Daniel P.
    Barrowman, Jemima
    Ap Rhys, Colette
    Simonson, Lisa
    Dietz, Harry C.
    Michaelis, Susan
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2013, 161A (07) : 1599 - 1611
  • [2] Familial accumulation of sudden cardiac deaths and the LMNA variant c.868G&gt;A (p.Glu290Lys)
    Finsterer, Josef
    Stllberger, Claudia
    Keller, Hans
    Gencik, Martin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 215 : 84 - 86
  • [3] Short stature in a boy with atypical progeria syndrome due to LMNA c.433G &gt; A [p.(Glu145Lys)]: apparent growth hormone deficiency but poor response to growth hormone therapy
    Toni, Ledjona
    Dusatkova, Petra
    Novotna, Dana
    Zemkova, Daniela
    Pruhova, Stepanka
    Lobl, Jan
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2019, 32 (07): : 775 - 779
  • [4] Homozygous p.(Glu87Lys) variant in ISCA1 is associated with a multiple mitochondrial dysfunctions syndrome
    Shukla, Anju
    Hebbar, Malavika
    Srivastava, Anshika
    Kadavigere, Rajagopal
    Upadhyai, Priyanka
    Kanthi, Anil
    Brandau, Oliver
    Bielas, Stephanie
    Girisha, Katta M.
    JOURNAL OF HUMAN GENETICS, 2017, 62 (07) : 723 - 727
  • [5] Homozygous p.(Glu87Lys) variant in ISCA1 is associated with a multiple mitochondrial dysfunctions syndrome
    Anju Shukla
    Malavika Hebbar
    Anshika Srivastava
    Rajagopal Kadavigere
    Priyanka Upadhyai
    Anil Kanthi
    Oliver Brandau
    Stephanie Bielas
    Katta M Girisha
    Journal of Human Genetics, 2017, 62 : 723 - 727
  • [6] A commentary on homozygous p.(Glu87Lys) variant in ISCA1 is associated with a multiple mitochondrial dysfunctions syndrome
    Finsterer, Josef
    Zarrouk-Mahjoub, Sinda
    JOURNAL OF HUMAN GENETICS, 2017, 62 (09) : 865 - 866
  • [7] A commentary on homozygous p.(Glu87Lys) variant in ISCA1 is associated with a multiple mitochondrial dysfunctions syndrome
    Josef Finsterer
    Sinda Zarrouk-Mahjoub
    Journal of Human Genetics, 2017, 62 : 865 - 866
  • [8] A Case of Hutchinson-Gilford Progeria Syndrome (HGPS) Due to a Pathogenic LMNA Variant c.433G&gt;A (p.Glu145Lys): Growth Hormone Administration Failed to Improve Growth and Long-Term Outcome
    Toni, Ledjona
    Dusatkoa, Petra
    Novotna, Dana
    Zemkova, Dana
    Pruhova, Stepanka
    Lebl, Jan
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 465 - 465
  • [9] A reply to a commentary on homozygous p.(Glu87Lys) variant in ISCA1 is associated with a multiple mitochondrial dysfunctions syndrome
    Anju Shukla
    Malavika Hebbar
    Katta M Girisha
    Journal of Human Genetics, 2017, 62 : 867 - 867
  • [10] A reply to a commentary on homozygous p.(Glu87Lys) variant in ISCA1 is associated with a multiple mitochondrial dysfunctions syndrome
    Shukla, Anju
    Hebbar, Malavika
    Girisha, Katta M.
    JOURNAL OF HUMAN GENETICS, 2017, 62 (09) : 867 - 867